Twenty-four-hour ambulatory heart rate and organ damage in primary hypertension

Blood Pressure

Volumn 19, Issue 2, 2010, Pages 104-109

  Fácila, Lorenzo ^a   Pallarés, Vicente ^b   Peset, Ana ^a   Pérez, Manuel ^c   Gil, Vicente ^d   Montagud, Vicente ^a   Bellido, Vicente ^a   Bertomeu Gonzalez, Vicente ^e   Redón, Josep ^f  

^a Servicio de Cardiologia   (Spain)

^b Unidad de Vigilancia de la Salud   (Spain)

^c Centro de Atención Primaria Villafranca Del Cid   (France)

^d MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

^e Hospital Universitario de San Juan de Alicante   (France)

^f Hospital Clinico   (Spain)

Author keywords

Arterial hypertension; Heart rate; Target organ damage

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ANTIHYPERTENSIVE AGENT;

ADULT; ARTICLE; BLOOD PRESSURE MONITORING; CARDIAC PATIENT; CARDIOVASCULAR RISK; DIABETES MELLITUS; DYSLIPIDEMIA; ESSENTIAL HYPERTENSION; FEMALE; HEART RATE; HIGH RISK POPULATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; ORGAN INJURY; PREVALENCE; PRIORITY JOURNAL; REGISTER; SMOKING; TARGET ORGAN; BLOOD PRESSURE; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASES; COMPLICATION; CROSS-SECTIONAL STUDY; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PATHOPHYSIOLOGY; PHYSIOLOGY; QUESTIONNAIRE; RISK FACTOR;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; FEMALE; HEART RATE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; QUESTIONNAIRES; RISK FACTORS;

EID: 77950606703     PISSN: 08037051     EISSN: 16511999     Source Type: Journal    
DOI: 10.3109/08037050903525103     Document Type: Article

References (26)

1. Kjekshus JK. Importance of heart rate in determining beta-blocker effi cacy in acute and long-term acute myocardial infarction intervention trials. Am J Cardiol. 1986;57: F43-F49.
2. Kjekshus J, Gullestad L. Heart rate as a therapeutic target in heart failure. Eur Heart J. 1999;1 Suppl:H64-H69.
3. Lechat P, Hulot JS, Escolano S, Mallet A, Leizorovicz A, Werhlen-Grandjean M, et al.. Heart rate and cardiac rhythm relationships with bisoprolol benefi t in chronic heart failure in CIBIS II Trial. Circulation. 2001;103:1428-1433.
4. Gillman MW, Kannel WB, Belanger A, D'Agostino RB. Infl uence of heart rate on mortality among persons with hypertension: The Framingham Study. Am Heart J. 1993;125: 1148-1154.
5. Wilhelmsen L, Berglund G, Elmfeldt D, Tibblin G, Wedel H, Pennert K, et al. . The multifactor primary prevention trial in Goteborg, Sweden. Eur Heart J. 1986;7:279-288.
6. Jouven X, Zureik M, Desnos M, Guerot C, Ducimetiere P. Resting heart rate as a predictive risk factor for sudden death in middle-aged men. Cardiovasc Res. 2001;50:373-378.
7. Hozawa A, Inoue R, Ohkubo T, Kikuya M, Metoki H, Asayama K, et al.. Predictive value of ambulatory heart rate in the Japanese general population: The Ohasama study. J Hypertens. 2008;26:1571-1576.
8. López-Sendón JL; López de Sá E. Reducción de la frecuencia cardiaca. Otras oportunidades terapéuticas. Rev Esp Cardiol. 2007;7:53-57.
9. Gorostidi M, Sobrino J, Segura J, Sierra C, de la Sierra A, Hernández del Rey R, et al..; for the Spanish Society of Hypertension Ambulatory Blood Pressure Monitoring Registry investigators. Ambulatory blood pressure monitoring in hypertensive patients with high cardiovascular risk: A crosssectional analysis of a 20,000-patient database in Spain. J Hypertens. 2007;25:977-984.
10. O'Brien E, Waeber B, Parati G, Staessen J, Myers MG. Blood pressure measuring devices: Recommendations of the European Society of Hypertension. Br Med J. 2001; 322:531-536.
11. Topouchian JA, El Assaad MA, Orobinskaia LY, El Feghali RN, Asmar RG. Validation of two automatic devices for selfmeasurement of blood pressure according to the International Protocol of the European Society of Hypertension: The Omron M6 (HEM-7001-E) and the Omron R7 (HEM-637- -IT). Blood Press Monit. 2006;11:165-171.
12. Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, Hill MN, et al.. Recommendations for blood pressure measurement in humans and experimental animals: Part 1: Blood pressure measurement in humans: A statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Hypertension. 2005;45: 142-161. (Pubitemid 40066429)
13. Ferrari R, Campo G, Gardini E, Pasanisi G, Ceconi C. Specifi c and selective I f inhibition: Expected clinical benefi ts from pure heart rate reduction in coronary patients. Eur Heart J. 2005;7 Suppl H:16-21.
14. Dyer AR, Persky V, Stamler J, Paul O, Shekelle RB, Berkson DM, et al.. Heart rate as a prognostic factor for coronary heart disease and mortality: Findings in three Chicago epidemiologic studies. Am J Epidemiol. 1980;112:736-749.
15. Kannel WB, Wilson P, Blair SN. Epidemiological assessment of the role of physical activity and fi tness in development of cardiovascular disease. Am Heart J. 1985;109:876-885.
16. Gillum RF. The epidemiology of resting heart rate in a national sample of men and women: Associations with hypertension, coronary heart disease, blood pressure, and other cardiovascular risk factors. Am Heart J. 1988;116:163-174.
17. Shaper AG, Wannamethee G, Macfarlane PW, Walker M. Heart rate, ischaemic heart disease, and sudden cardiac death in middle-aged British men. Br Heart J. 1993;70:49-55.
18. Jouven X, Desnos M, Guerot C, Ducimetiere P. Predicting sudden death in the population: The Paris Prospective Study I. Circulation. 1999;99:1978-1983.
19. Palatini P, Casiglia E, Julius S, Pessina AC. High heart rate: A risk factor for cardiovascular death in elderly men. Arch Intern Med.1999;159:585- 592.
20. Palatini P, Julius S. Heart rate and the cardiovascular risk. J Hypertens. 1997;15:3-17.
21. Erikssen J, Rodahl K. Resting heart rate in apparently healthy middle-aged men. Eur J Appl Physiol Occup Physiol. 1979; 42:61-69.
22. Berenson GS, Voors AW, Webber LS, Dalferes ER Jr, Harsha DW. Racial differences of parameters associated with blood pressure levels in children - The Bogalusa heart study. Metabolism. 1979;28:1218-1228.
23. Greenland P, Daviglus ML, Dyer AR, Liu K, Huang CF, Goldberger JJ, et al.. Resting heart rate is a risk factor for cardiovascular and non-cardiovascular mortality: The Chicago Heart Association Detection Project in Industry. Am J Epidemiol. 1999;149:853-862.
24. Kristal-Boneh E, Silber H, Harari G, Froom P. The association of resting heart rate with cardiovascular, cancer and all-cause mortality. Eight year follow-up of 3527 male Israeli employees (the CORDIS Study). Eur Heart J. 2000;21: 116-124.
25. Mo R, Nordrehaug JE, Omvik P, Lund-Johansen P. The Bergen Blood Pressure Study: Prehypertensive changes in cardiac structure and function in offspring of hypertensive families. Blood Press. 1995;4:16-22.
26. Hansen TW, Thijs L, Boggia J, Li Y, Kikuya M, Björklund- Bodegård K, et al..; International Database on Ambulatory Blood Pressure in Relation to Cardiovascular Outcomes Investigators. Prognostic value of ambulatory heart rate revisited in 6928 subjects from 6 populations. Hypertension 2008;52:229-235.